首页> 外国专利> IMPROVED DELIVERY BY PRIMARY COMPOUNDS OF ANTICANCEROSO AGENT TO SOLID TUMORS

IMPROVED DELIVERY BY PRIMARY COMPOUNDS OF ANTICANCEROSO AGENT TO SOLID TUMORS

机译:抗肿瘤药的主要化合物可改善固体肿瘤的递送

摘要

Primer compositions for anti-cancer agent delivery to solid tumors in mammals, including man, are disclosed. The primer comprise a pharmaceutically acceptable agent which increases the intracellular levels of cyclic adenosine monophosphate (cAMP) in the normal connective tissue cells within solid tumors. Such an agent may be selected from any agents which increase the intracellular levels of cAMP, e.g. agents binding to and stimulating receptors at the connective tissue cell surface within tumors, and agents inhibiting cAMP phosphodiesterase. Local administration of the primer to the solid tumor area results in a lowering of the interstitial pressure. Further, an agent delivery system and a method for delivery of anti-cancer agents to solid tumors are described.
机译:公开了用于将抗癌剂递送至包括人在内的哺乳动物的实体瘤中的引物组合物。引物包含药学上可接受的试剂,该试剂增加实体瘤内正常结缔组织细胞中环磷酸腺苷(cAMP)的细胞内水平。这样的试剂可以选自增加cAMP的细胞内水平的任何试剂,例如。与肿瘤内结缔组织细胞表面的受体结合并刺激它们的药物,以及抑制cAMP磷酸二酯酶的药物。将引物局部施用至实体瘤区域导致间质压力降低。此外,描述了一种药物递送系统和一种将抗癌药物递送至实体瘤的方法。

著录项

  • 公开/公告号PT977559E

    专利类型

  • 公开/公告日2003-02-28

    原文格式PDF

  • 申请/专利权人 BIOPHAUSIA AB;

    申请/专利号PT19980930728T

  • 发明设计人 KRISTOFER RUBIN;MATS SJOQUIST;ROLF REED;

    申请日1998-05-26

  • 分类号A61K31/135;A61K31/557;A61K31/35;A61K31/52;A61K31/40;A61K38/04;A61K38/17;

  • 国家 PT

  • 入库时间 2022-08-22 00:01:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号